Loading…
Reported covered position: Vice President, Policy and Regulatory Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 3630, the Middle Class Tax Relief and Job Creation Act of 2012 (PL 112-96)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2013 · first_quarter · Q1
Medicare Clinical Laboratory Fee Schedule reimbursement issues; regulation of laboratory-developed tests; closing the in-office ancillary services exemption to the Stark law; and health reform law implementation issues, including application of the medical device tax to clinical laboratories.
Medicare Clinical Laboratory Fee Schedule reimbursement issues; regulation of laboratory-developed tests; closing the in-office ancillary services exemption to the Stark law; and health reform law implementation issues, including application of the medical device tax to clinical laboratories.
Source: Senate LDA
Health reform law implementation issues including application of medical device tax to clinical laboratories; in-office ancillary services exception to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards for Patients Act; H.R. 6118.S.3391, the Taking Essential Steps for Testing Act; the coding and pricing and placement of molecular pathology laboratory tests
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule cuts; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 5651, Food and Drug Administration Reform Act, S. 3187, Food and Drug Administration Safety and Innovation Act, HR 6118, the Taking Essential Steps for Testing Act
Food and Drug Administration Reform Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule cuts; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 5651, Food and Drug Administration Reform Act, S. 3187, Food and Drug Administration Safety and Innovation Act, HR 6118, the Taking Essential Steps for Testing Act
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of medical device tax to clinical laboratories; in-office ancillary services exception to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards for Patients Act; H.R. 6118.S.3391, the Taking Essential Steps for Testing Act; the coding and pricing and placement of molecular pathology laboratory tests
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Taking Essential Steps for Testing Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule cuts; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 5651, Food and Drug Administration Reform Act, S. 3187, Food and Drug Administration Safety and Innovation Act, HR 6118, the Taking Essential Steps for Testing Act
American Taxpayer Relief Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
American Taxpayer Relief Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
American Taxpayer Relief Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
American Taxpayer Relief Act of 2012
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule; HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control ACt of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 3630, the Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, the Temporary Payroll Tax Cut Continuation Act of 2011 (PL 112-78); Medicare laboratory co-insurance and co-payments
Temporary Payroll Tax Cut Continuation Act of 2011
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule; HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control ACt of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 3630, the Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, the Temporary Payroll Tax Cut Continuation Act of 2011 (PL 112-78); Medicare laboratory co-insurance and co-payments
Medicare Clinical Laboratory Fee Schedule reimbursement issues; regulation of laboratory-developed tests; closing the in-office ancillary services exemption to the Stark law; and health reform law implementation issues, including application of the medical device tax to clinical laboratories.
Medicare Clinical Laboratory Fee Schedule reimbursement issues; regulation of laboratory-developed tests; closing the in-office ancillary services exemption to the Stark law; and health reform law implementation issues, including application of the medical device tax to clinical laboratories.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2012 · fourth_quarter · RA
Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.
Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.
Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.
Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2012 · fourth_quarter · 4A
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), President of the U.S., SENATE
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2012 · fourth_quarter · 4T
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), President of the U.S., SENATE
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2012 · third_quarter · Q3
Health reform law implementation issues including application of medical device tax to clinical laboratories; in-office ancillary services exception to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards for Patients Act; H.R. 6118.S.3391, the Taking Essential Steps for Testing Act; the coding and pricing and placement of molecular pathology laboratory tests
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2012 · second_quarter · Q2
Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule cuts; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 5651, Food and Drug Administration Reform Act, S. 3187, Food and Drug Administration Safety and Innovation Act, HR 6118, the Taking Essential Steps for Testing Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2012 · first_quarter · Q1
Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 3630, the Middle Class Tax Relief and Job Creation Act of 2012 (PL 112-96)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2011 · fourth_quarter · Q4
health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule; HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control ACt of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 3630, the Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, the Temporary Payroll Tax Cut Continuation Act of 2011 (PL 112-78); Medicare laboratory co-insurance and co-payments
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2011 · third_quarter · Q3
Health reform law implementation issues including application of the medical device tax to clinical lab tests and the clinical laboratory fee schedule; legislation regarding FDA oversight of laboratory developed tets; Budget Control Act of 2011; proposals concerning the Stark Law's in-office ancillary services exception; Medicare laboratory co-insurance and co-payments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), President of the U.S., SENATE